Table 1.
Breakdown of the patient population (N = 441).
| Characteristic | Value | |
|---|---|---|
| Age | 56 [47, 70] | |
| Volpara density | 14.7% [9.2, 20.7] | |
| Suspicious calcifications | Yes | 193 (43.8%) |
| No | 248 (56.2%) | |
| MMG category | 1.2 (non-detected) | 82 (18.6%) |
| 3.4.5 (detected) | 359 (81.4%) | |
| US category | 1.2 (non-detected) | 48 (10.9%) |
| 3.4.5 (detected) | 393 (89.1%) | |
| Neoadjuvant chemotherapy/preoperative hormone therapy | Yes | 55 (12.5%) |
| No | 386 (87.5%) | |
| Invasion | Yes | 354 (80.3%) |
| No | 87 (19.7%) | |
| Size of invasion | 12.5 mm [5, 22] | |
| Method of diagnosis | Symptomatic | 81 (18.4%) |
| Screening | 147 (33.3%) | |
| Referred | 129 (29.3%) | |
| Others | 84 (19%) |
MMG, mammography; US, ultrasonography. Presented statistics: Median [25%, 75%]; n (%).